Cellvera Receives $20M Purchase Order for COVID-19 Oral Antiviral Avigan®
DUBAI, Arab Emirates - January 24, 2022 - (Newswire.com) Cellvera, a global biopharmaceutical company developing and commercializing innovative antiviral therapies, and the Global Response Aid today announced a supply of millions of its COVID-19 oral antiviral Avigan® to Malaysia in...
Source: pharmiweb.com